找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Serious Games: The Challenge; ITEC/CIP/T 2011: Joi Stefan Wannemacker,Sylke Vandercruysse,Geraldine C Conference proceedings 2012 Springer-

[復(fù)制鏈接]
樓主: 契約
31#
發(fā)表于 2025-3-26 22:46:21 | 只看該作者
Marjoke Bakker,Marja van den Heuvel-Panhuizen,Sylvia van Borkulo,Alexander RobitzschIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10?MKD) is bein
32#
發(fā)表于 2025-3-27 01:15:26 | 只看該作者
Charles-Frederik Hollemeersch,Bart Pieters,Peter Lambert,Rik Van de WalleIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10?MKD) is bein
33#
發(fā)表于 2025-3-27 05:34:34 | 只看該作者
Sylvia van Borkulo,Marja van den Heuvel-Panhuizen,Marjoke Bakker,Hanneke Loomansshown excellent performance on the Indian subcontinent, but the latter is preferred, as it is simpler to use. The proper implementation of these diagnostic strategies within the VL elimination program involves not only the procurement, training, and supervision of staff, but also quality control bot
34#
發(fā)表于 2025-3-27 12:20:55 | 只看該作者
35#
發(fā)表于 2025-3-27 14:54:13 | 只看該作者
Pau Yanez,Xavier Maseffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza
36#
發(fā)表于 2025-3-27 19:16:22 | 只看該作者
Jan-Henk Annema,Yorick Poels,Bieke Zaman,Frederik Cornillieeffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza
37#
發(fā)表于 2025-3-28 01:36:43 | 只看該作者
38#
發(fā)表于 2025-3-28 05:49:17 | 只看該作者
39#
發(fā)表于 2025-3-28 06:52:38 | 只看該作者
40#
發(fā)表于 2025-3-28 13:06:46 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 23:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长治县| 澎湖县| 兴城市| 清远市| 当雄县| 察隅县| 济源市| 宁蒗| 清镇市| 湄潭县| 安达市| 吉林省| 永德县| 卢氏县| 木兰县| 纳雍县| 叶城县| 雅安市| 黎城县| 宁远县| 广宗县| 临清市| 两当县| 额济纳旗| 隆德县| 崇仁县| 萨迦县| 扶余县| 三台县| 巴青县| 白银市| 海盐县| 安阳县| 信阳市| 永仁县| 马关县| 荥经县| 新郑市| 西宁市| 桂林市| 云浮市|